The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

NCT05195242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

445

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Thrombosis Embolism
Bleeding

Interventions

DRUG: Dexamethasone

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]